Academic literature on the topic 'Cinitapride'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cinitapride.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cinitapride"

1

&NA;. "Cinitapride." Reactions Weekly &NA;, no. 1312 (2010): 18. http://dx.doi.org/10.2165/00128415-201013120-00060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Roy, Shikha M. N., Santos H. M. Yetal, Sangita V. Chavan, Vara D. R. Pradhan, and Santosh S. Joshi. "Determination of Free Levels of Cinitipride in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry." E-Journal of Chemistry 5, no. 3 (2008): 453–60. http://dx.doi.org/10.1155/2008/242986.

Full text
Abstract:
A rapid, sensitive and specific method to quantify cinitapride in human plasma using risperidone as the internal standard is described. Sample preparation involved simple solid phase extraction procedure. The extract was analyzed by high performance liquid chromatography coupled to electrospray tandem mass spectrometry API-4000 (LC-MS/MS). Chromatography was performed isocratically on Thermo Hypurity C18analytical column, (50 mm x 4.6 mm, 5µm i.d.). The assay of cinitapride was linear calibration curve over the range 20.118 pg mL−1to 2011.797 pg mL−1. Plasma concentrations of cinitapride were
APA, Harvard, Vancouver, ISO, and other styles
3

Roy, S. M. N., Kiran V. Mangaonkar, A. Y. Desai, and Santosh M. Yetal. "RP-HPLC Method for the Determination of Cinitapride in the Presence of its Degradation Products in Bulk Drug." E-Journal of Chemistry 7, no. 1 (2010): 311–19. http://dx.doi.org/10.1155/2010/259507.

Full text
Abstract:
A reverse phase HPLC method is described for the determination of cinitapride hydrogen tartrate in the presence of its degradation products in bulk drug. A drug was subjected to all stress conditions such as reduction, oxidation acidic and alkaline medium. Chromatography was recorded on an Intersil ODS-3 column using mixture of acetonitrile and phosphate buffer, pH adjusted to 6.7 in the ratio (70:30 v/v) as the mobile phase at the rate of 1.0 mL/min with detection at 260 nm. Glimepride was used as internal standard. The retention time of drug cinitapride was 3.8 min and glimepride an internal
APA, Harvard, Vancouver, ISO, and other styles
4

Dighade, N. R., S. P. Padmane, and A. V. Kasture. "A VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF PANTOPRAZOLE AND CINITAPRIDE IN A PHARMACEUTICAL FORMULATION." INDIAN DRUGS 51, no. 01 (2014): 27–33. http://dx.doi.org/10.53879/id.51.01.p0027.

Full text
Abstract:
The study describes a validated stability indicating reverse- phase HPLC method for the simultaneous estimation of pantoprazole and cinitapride in capsule formulation. The proposed RP-HPLC method utilizes an Eclipse XDB C18 Column (150 × 4.6 mm i.d., 5μm), optimum mobile phase consisting of 10 mM phosphate buffer: acetonitrile: THF in the ratio of 64:36:0.5 V/V (pH 3.5) V/V, effluent flow rate 1 mL/min and UV detection wavelength of 266 nm. The selected chromatographic conditions were found to effectively separate pantoprazole and cinitapride with retention time of 7.17 min and 3.56 min, respe
APA, Harvard, Vancouver, ISO, and other styles
5

Humaira, Syeda, Akalanka Dey, S. Appala Raju, and Syed Sanaullah. "Development and Validation of a Rapid RP HPLC Method for the Determination of Cinitapride Hydrogen Tartarate in Solid Oral Dosage Forms." E-Journal of Chemistry 8, no. 3 (2011): 1424–29. http://dx.doi.org/10.1155/2011/614160.

Full text
Abstract:
In the present study a simple, sensitive rapid and accurate HPLC method with UV detection for the analysis of cinitapride hydrogen tartarate was developed and validated in solid dosage forms. The method utilized gradient elution technique with C18 column (150×4.6 mm I.D, 5 μm particle size) with mobile phase consisting of 0.1% formic acid in water and acetonitrile The detection wavelength was at 268 nm, with flow rate of 0.5 mL/min and injection volume of 10 μL for separation of cinitapride in bulk drugs and pharmaceutical formulations. The gradient elution was developed for better and optimiz
APA, Harvard, Vancouver, ISO, and other styles
6

González Martı́n, I., C. González Pérez, and M. A. Blanco López. "Polarographic determination of cisapride and cinitapride." Analytica Chimica Acta 368, no. 1-2 (1998): 175–81. http://dx.doi.org/10.1016/s0003-2670(98)00055-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Thangabalan, Boovizhikannan, Getu Kahsay, and Tadele Eticha. "Development and Validation of a High-Performance Liquid Chromatographic Method for the Determination of Cinitapride in Human Plasma." Journal of Analytical Methods in Chemistry 2018 (August 28, 2018): 1–5. http://dx.doi.org/10.1155/2018/8280762.

Full text
Abstract:
A precise and reliable reversed-phase high-performance liquid chromatographic method with ultraviolet detection was developed and validated to determine cinitapride in human plasma. After liquid-liquid extraction, chromatographic separation was achieved on a Nucleosil C18 (25 cm × 4.6 mm, 5 µm) column with an isocratic elution consisting of 10 mM ammonium acetate (pH 5.2), methanol, and acetonitrile, 40 : 50 : 10, v/v/v. The developed method was validated as per US FDA guidelines for its linearity, selectivity, sensitivity, precision, accuracy, and stability. Satisfactory findings were obtaine
APA, Harvard, Vancouver, ISO, and other styles
8

Rijhwani, Puneet, Agarwal C M, Mohammed Shoaib, Prerna Upadhyaya, and Pradeep Agarwal. "EFFICACY OF CINITAPRIDE HYDROGEN TARTARATE IN GERD." Journal of Evidence Based Medicine and Healthcare 1, no. 8 (2014): 1073–79. http://dx.doi.org/10.18410/jebmh/2014/157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fernandez, A. G., and D. J. Roberts. "Cinitapride Hydrogen Tartrate < Rec INNM >." Drugs of the Future 16, no. 10 (1991): 885. http://dx.doi.org/10.1358/dof.1991.016.10.151174.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Slíva, Jiří. "Cinitaprid expands treatment options for functional dyspepsia." Gastroenterologie a hepatologie 78, no. 5 (2024): 441–43. http://dx.doi.org/10.48095/ccgh2024441.

Full text
Abstract:
reatment of functional dyspepsia is often medically difficult and requires a comprehensive approach, including the drug group prokinetics. In the Czech Republic, it is now being expanded to include the active substance cinitapride. The presented text summarizes its basic pharmacological properties and summarizes the available relevant aspects of its clinical use.
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!